Your Niche CRO

Symbio is a client-focused, full-service contract research organization (CRO) specializing in dermatology, aesthetics, gastroenterology, and inflammatory diseases.

As your niche CRO, we take uncertainty out of every study with complete transparency, exemplary execution, and clinical excellence grounded in 20+ years of experience.

Why Do Sponsors Choose Symbio?

Sponsors trust Symbio as their specialized CRO because we offer impactful benefits compared to large, generalist CROs.

Large CRO

Symbio

  • Senior resources prioritized for large accounts
  • Every study receives senior, indication-experienced A-team members
  • High turnover; disrupted continuity and repeated onboarding
  • Above-average employee longevity ensures stable teams and retained program knowledge
  • Transactional engagement; rigid corporate layers
  • True partnership aligned with sponsor goals and long-term collaboration
  • Sites selected by standardized feasibility
  • Strategic long-term site relationships aligned with study objectives
  • Bureaucratic systems, slower decision-making
  • Flat hierarchies and robust yet flexible SOPs for rapid adaptation
  • Large theoretical capacity but slower activation
  • Streamlined operations allow efficient and rapid scale-up
  • Fragmented teams with surface-level knowledge of various therapeutic areas
  • Decades of retained expertise in specific therapeutic areas to help navigate complex patient populations, study designs, and regulatory demands
  • Frequent change orders
  • Thoughtful planning and accurate scoping minimize changes and keep invoicing to 96% of the original contract, on average

How Did Symbio Become a Specialty CRO?

2023

Logos for Symbio, Dow Development Laboratories LLC, and Proinnovera.

In November of 2023, Symbio, LLC and Dow Development Laboratories, LLC merged with Proinnovera to create Symbio Proinnovera, one of the world’s largest dermatology-focused clinical research organizations.

International Footprint

With global clinical trial capabilities across North America, Europe, Australia, and subsidiaries around the globe, we offer optimal team alignment and end-to-end services worldwide.

Dow Development Office

Dow Development

California, U.S.

Symbio Logo Icon

Symbio

New York, U.S.

Symbio Logo Icon

Symbio

Münster, Germany

Symbio Logo Icon

Symbio

India (Remote)

Symbio Logo Icon

Symbio

Melbourne, Australia

The Symbio Site Network

As a niche CRO, we take great pride in the strong relationships we have established with specialized sites and investigators over the years. With our high-performing sites by our side, we streamline recruitment and deliver shorter enrollment timelines.

Sponsors: Wondering what else the Symbio network can do for your trial?

Explore Our Network

Investigators: Interested in joining our site network?

Reach Out Now
A smiling male doctor in a white coat and stethoscope reaches across a desk to shake hands with a patient during a consultation."
Professional headshot of a bald man wearing glasses, a navy blazer, and a blue tie, smiling against a blurred blue background.

A Message From
Symbio Leadership

At Symbio, our clients are the core of everything we do. We recognize the significant responsibility of bringing drugs and devices to market, and we are truly honored to be chosen as a partner to help guide this critical journey.

With a vast network of experts across specialized therapeutic areas and global regions, we provide customized solutions tailored to meet the unique needs of each client.

Our reputation is built on the principle that ‘the reward for good work is more work.’ As your specialty CRO and committed partner, we remain dedicated to delivering exceptional service every step of the way.

  — Alan Morgan, Symbio Executive Chairman

Impactful expertise and true partnership. Give your trial the Symbio touch.

Contact Us Now